Age-dependent vascular changes induced by status epilepticus in rat forebrain: Implications for epileptogenesis

Neurobiology of Disease

Volumn 34, Issue 1, 2009, Pages 121-132

  Marcon, Jessica ^a   Gagliardi, Barbara ^a   Balosso, Silvia ^a   Maroso, Mattia ^a   Noé, Francesco ^a   Morin, Mèlanie ^b   Lerner Natoli, Mireille ^b   Vezzani, Annamaria ^a   Ravizza, Teresa ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

Author keywords

Albumin; Angiogenesis; BBB; IL 1 ; Inflammation; Status epilepticus

Indexed keywords

AGE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; CHRONIC INFLAMMATION; CONTROLLED STUDY; EPILEPTIC STATE; EPILEPTOGENESIS; FOREBRAIN; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AGING; ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; ENCEPHALITIS; FLUORESCEIN-5-ISOTHIOCYANATE; GENES, FOS; HIPPOCAMPUS; IMMUNOGLOBULIN G; INTERLEUKIN-1BETA; MALE; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; NEURONS; PILOCARPINE; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN; STATUS EPILEPTICUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 62549139615     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.12.018     Document Type: Article

References (66)

1. Abbott J.N. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell. Mol. Neurobiol. 20 (2000) 131-147
2. Allan S.M., et al. Interleukin-1 and neuronal injury. Nat. Rev., Immunol. 5 (2005) 629-640
3. Alon T., et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1 (1995) 1024-1028
4. Andras I.E., et al. The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cells. J. Cereb. Blood Flow Metab. 27 (2007) 1431-1443
5. Anthony D.C., et al. Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain 120 Pt 3 (1997) 435-444
6. Argaw A.T., et al. IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J. Immunol. 177 (2006) 5574-5584
7. Auvin S., et al. Inflammation exacerbates seizure-induced injury in the immature brain. Epilepsia 48 suppl. 5 (2007) 27-34
8. Ballabh P., et al. Development of tight junction molecules in blood vessels of germinal matrix, cerebral cortex, and white matter. Pediatr. Res. 58 (2005) 791-798
9. Bendfeldt K., et al. Basic fibroblast growth factor modulates density of blood vessels and preserves tight junctions in organotypic cortical cultures of mice: a new in vitro model of the blood-brain barrier. J. Neurosci. 27 (2007) 3260-3267
10. Bernardino L., et al. Modulator effects of interleukin 1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. J. Neurosci. 25 (2005) 6734-6744
11. Bezzi P., et al. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4 (2001) 702-710
12. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 438 (2005) 932-936
13. Carmeliet P., and Tessier-Lavigne M. Common mechanisms of nerve and blood vessel wiring. Nature 436 (2005) 193-200
14. Casamenti F., et al. Interleukin-1beta activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's disease. Neuroscience 91 (1999) 831-842
15. De Simoni M.G., et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur. J. Neurosci. 12 (2000) 2623-2633
16. de Vries H.E., et al. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol. 64 (1996) 37-43
17. Del Maschio A., et al. Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions. J. Cell Biol. 135 (1996) 497-510
18. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 87 (1996) 2095-2147
19. Dubé C., et al. C-Fos, Jun D and HSP72 immunoreactivity, and neuronal injury following lithium-pilocarpine induced status epilepticus in immature and adult rats. Brain Res. Mol. Brain Res. 63 (1998) 139-154
20. Dubé C., et al. Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann. Neurol. 57 (2005) 152-155
21. Fabene P.F., et al. Magnetic resonance imaging of changes elicited by status epilepticus in the rat brain: diffusion-weighted and T2-weighted images, regional blood volume maps, and direct correlation with tissue and cell damage. NeuroImage 18 (2003) 375-389
22. Giulian D., et al. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 8 (1988) 2485-2490
23. Greenberg D.A., and Jin K. From angiogenesis to neuropathology. Nature 438 (2005) 954-959
24. Hallmann R., et al. Expression and function of laminins in the embryonic and mature vasculature. Physiol. Rev. 85 (2005) 979-1000
25. Heida J.G., and Pittman Q.J. Causal links between brain cytokines and experimental febrile convulsions in the rat. Epilepsia 46 (2005) 1906-1913
26. Hellsten J., et al. Electroconvulsive seizures induce angiogenesis in adult rat hippocampus. Biol. Psychiatry 58 (2005) 871-878
27. Hirsch E., et al. Ontogenic study of lithium-pilocarpine-induced status epilepticus in rats. Brain Res. 583 (1992) 120-126
28. Hu S., et al. Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 7 (2000) 153-159
29. Ivens S., et al. TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 130 (2007) 535-547
30. Kubova H., et al. Status epilepticus in immature rats leads to behavioural and cognitive impairment and epileptogenesis. Eur. J. Neurosci. 19 (2004) 3255-3265
31. Marchi N., et al. Determinants of drug brain uptake in a rat model of seizure-associated malformations of cortical development. Neurobiol. Dis. 24 (2006) 429-442
32. Marchi N., et al. In vivo and in vitro effects of pilocarpine: relevance to ictogenesis. Epilepsia 48 (2007) 1934-1946
33. Marchi N., et al. Seizure-promoting effect of blood-brain barrier disruption. Epilepsia 48 (2007) 732-742
34. Morgan J.I., and Curran T. Proto-oncogene transcription factors and epilepsy. Trends Neurosci. 12 (1991) 459-462
35. Nagy J.A., et al. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis 11 (2008) 109-119
36. Naldini A., and Carraro F. Role of inflammatory mediators in angiogenesis. Curr. Drug Targets Inflamm. Allergy 4 (2005) 3-8
37. Neuwelt E.A., et al. Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma. Neurosurgery 19 (1986) 573-582
38. Nicoletti J.N., et al. Vascular endothelial growth factor is up-regulated after status epilepticus and protects against seizure-induced neuronal loss in hippocampus. Neuroscience 151 (2008) 232-241
39. Noé F., et al. Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy. Brain 131 (2008) 1506-1515
40. Oby E., and Janigro D. The blood-brain barrier and epilepsy. Epilepsia 47 (2006) 1761-1774
41. Paxinos, G., Watson, C., 1986. The rat brain in stereotaxic coordinates. Academic Press, New York.
42. Pereira de Vasconcelos A., et al. Local cerebral blood flow during lithium-pilocarpine seizures in the developing and adult rat: role of coupling between blood flow and metabolism in the genesis of neuronal damage. J. Cereb. Blood Flow Metab. 22 (2002) 196-205
43. Priel M.R., et al. Developmental aspects of the pilocarpine model of epilepsy. Epilepsy Res. 26 (1996) 115-121
44. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32 (1972) 281-294
45. Ravizza, et al. The IL-1β system in epilepsy-associated malformations of cortical development. Neurobiol. Dis. 24 (2006) 128-143
46. Ravizza T., et al. Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy. Epilepsia 47 (2006) 1160-1168
47. Ravizza T., et al. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis. 29 (2008) 142-160
48. Ravizza T., et al. Interleukin converting enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production. Neurobiol. Dis. 31 (2008) 327-333
49. Rigau V., et al. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain 130 (2007) 1942-1956
50. Rizzi M., et al. Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development. Neurobiol. Dis. 14 (2003) 494-503
51. Roch C., et al. Predictive value of cortical injury for the development of temporal lobe epilepsy in 21-day-old rats: an MRI approach using the lithium-pilocarpine model. Epilpesia 43 (2002) 1129-1136
52. Sankar R., et al. Patterns of status epilepticus-induced neuronal injury during development and long-term consequences. J. Neurosci. 18 (1998) 8382-8393
53. Scantlebury M.H., et al. Age-dependent consequences of status epilepticus: animal models. Epilepsia 48 Suppl. 2 (2007) 75-82
54. Schmitz C., and Hof P.R. Design-based stereology in neuroscience. Neuroscience 130 (2005) 813-831
55. Schulze C., and Firth J.A. Interendothelial junctions during blood-brain barrier development in the rat: morphological changes at the level of individual tight junctional contacts. Brain Res. Dev. 69 (1992) 85-95
56. Seiffert E., et al. Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J. Neurosci. 24 (2004) 7829-7836
57. Storkebaum E., et al. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26 (2004) 943-954
58. van Vliet E.A., et al. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 130 (2007) 521-534
59. Vezzani A., and Baram T.Z. New roles for interleukin-1beta in the mechanism of epilepsy. Epilepsy Curr. 7 (2007) 45-50
60. Vezzani A., and Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46 (2005) 1724-1743
61. Vezzani A., et al. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J. Neurosci. 19 (1999) 5054-5065
62. Vezzani A., et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 11534-11539
63. Viviani B., et al. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 23 (2003) 8692-8700
64. Wang S., et al. Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons. J. Pharmacol. Exp. Ther. 292 (2000) 497-504
65. Ye Z.C., and Sontheimer H. Cytokine modulation of glial glutamate uptake: a possible involvement of nitric oxide. NeuroReport 7 (1996) 2181-2185
66. Zeise M.L., et al. Interleukin-1beta does not increase synaptic inhibition in hippocampal CA3 pyramidal and dentate gyrus granule cells of the rat in vitro. Brain Res. 768 (1997) 341-344